Markets:

Overview

News

Currencies

International

Treasuries

Eli Lilly (NY:LLY)

1,208.12 +80.43 (+7.13%)

Official Closing Price Updated: 7:00 PM EDT, Jun 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2

...

25 26 27 28 29 30 31 32 33

...

99 100 Next >

Eli Lilly Reinforces Immunology Dominance with $1.2 Billion Acquisition of Ventyx Biosciences

January 27, 2026

In a decisive move to solidify its leadership in the next generation of chronic inflammation and cardiometabolic treatments, Eli Lilly and Company (NYSE: LLY) announced the acquisition of Ventyx...

Via MarketMinute

1 Pharmaceutical Stock Set to Rebound in 2026 ↗

January 27, 2026

Novo Nordisk stock will ride a wave of demand for Ozempic pills in 2026.

Via The Motley Fool

Carvina Capital: Strong Demand Lifts Aktis IPO

January 27, 2026

Via AB Newswire

Up 36%, Is Eli Lilly Still a Buy? ↗

January 27, 2026

Thanks to its weight loss and diabetes products, the drug company has seen its shares soar.

Via The Motley Fool

Eli Lilly & Co (NYSE:LLY) Presents a Compelling Mix of Fundamental Growth and Technical Breakout Potential ↗

January 26, 2026

Via Chartmill

Novo Nordisk In Green After Oral Wegovy Clocks Over 18K Prescriptions In A Week ↗

January 23, 2026

Via Stocktwits

ELI LILLY & CO (NYSE:LLY) Offers a Durable Dividend with Strong Growth and Financial Health ↗

January 23, 2026

Via Chartmill

Where Will Eli Lilly Be in 10 Years? ↗

January 27, 2026

Eli Lilly is the leader in GLP-1 weight loss drugs today, but that advantage won't last forever.

Via The Motley Fool

Topics ETFs Intellectual Property

2 Profitable Stocks to Own for Decades and 1 Facing Headwinds

January 26, 2026

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Via StockStory

A Look Back at Pharmaceuticals Stocks’ Q3 Earnings: Ocular Therapeutix (NASDAQ:OCUL) Vs The Rest Of The Pack

January 26, 2026

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Ocular Therapeutix...

Via StockStory

Topics Artificial Intelligence Intellectual Property

The Silicon Laureates: How the 2024 Nobel Prizes Rewrote the Rules of Scientific Discovery

January 26, 2026

The year 2024 marked a historic inflection point in the history of science, as the Royal Swedish Academy of Sciences awarded Nobel Prizes in both Physics and Chemistry to pioneers of artificial...

Via TokenRing AI

Topics Artificial Intelligence

Eli Lilly or Viking Therapeutics: Which Stock Is More Likely to be a Millionaire-Maker? ↗

January 26, 2026

Both companies may succeed in this industry.

Via The Motley Fool

A Look Into Eli Lilly and Co Inc's Price Over Earnings ↗

January 26, 2026

Via Benzinga

The $6 Billion Disconnect: Why Revolution Medicines (RVMD) Plunged 20% After Merck Talks Collapsed

January 26, 2026

The biotechnology sector has always been a high-stakes arena where clinical success can create multi-billion-dollar empires overnight, and a failed negotiation can erase a fifth of a company’s market...

Via Finterra

Topics Economy Initial Public Offering

Prediction: This Healthcare Stock Could Soar by 40% in 2026 ↗

January 26, 2026

This pharmaceutical giant has recently caught fire, and the stock's run is likely just beginning.

Via The Motley Fool

My Top AI Healthcare Stock to Buy and Hold for 20 Years ↗

January 26, 2026

This drugmaker continues to strengthen its investment thesis.

Via The Motley Fool

Topics Artificial Intelligence Intellectual Property

3 Mid-Cap Stocks with Open Questions

January 25, 2026

Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with...

Via StockStory

3 Growth Stocks to Invest $1,000 in Right Now ↗

January 24, 2026

It comes as no surprise that all three of them are capitalizing on relatively new, but game-changing, developments.

Via The Motley Fool

Topics Artificial Intelligence

Should You Dump Eli Lilly's Shares After This Setback? ↗

January 24, 2026

The company got some bad news to start 2026.

Via The Motley Fool

Google, Nvidia, Lilly Lead 5 Stocks Near Buy Points ↗

January 24, 2026

These trillion-dollar stocks may be setting up for their next move.

Via Investor's Business Daily

The $5 Trillion Renaissance: How 2025 Redefined Global Deal-Making

January 23, 2026

The global financial landscape has undergone a seismic shift as 2025 closed with merger and acquisition (M&A) volumes surpassing a staggering $5 trillion. This "M&A Renaissance" marks a definitive end...

Via MarketMinute

Topics Artificial Intelligence Economy

Should You Forget Eli Lilly and Buy These Unstoppable Stocks Instead? ↗

January 23, 2026

Eli Lilly's valuation has been driven higher by investor excitement around GLP-1 drugs, leaving other drugmakers languishing.

Via The Motley Fool

Why a 15% Dividend Wasn’t Enough to Keep This $3.3 Million Position ↗

January 23, 2026

Trinity Capital provides venture debt and equipment financing to growth-stage tech companies seeking non-dilutive capital solutions.

Via The Motley Fool

Topics Regulatory Compliance

Outfront Media Surges 40% in One Year, Then Gets Cut Loose Despite 'Exceptional Performance' ↗

January 23, 2026

This out-of-home advertising REIT connects brands with urban audiences through a broad network of billboard and transit assets.

Via The Motley Fool

Topics Regulatory Compliance

Viking Therapeutics (VKTX) 2026 Deep Dive: Challenging the Obesity Duopoly

January 23, 2026

Date: January 23, 2026 Introduction In the high-stakes arena of metabolic medicine, few companies have generated as much speculative fervor and clinical awe as Viking Therapeutics (NASDAQ: VKTX). As of...

Via Finterra

Topics Intellectual Property

Oral Wegovy Is Off To An Astronomical Launch. Will It Save Novo Nordisk Stock? ↗

January 23, 2026

Novo Nordisk stock rose Friday on report its oral Wegovy clocked 18,000 prescriptions in its second week on the market.

Via Investor's Business Daily

Eli Lilly Soared by 39% in 2025, but Here's Another Healthcare Stock to Buy in 2026 ↗

January 23, 2026

This biotech has candidates in late-stage clinical development.

Via The Motley Fool

2 Mega-Cap Stocks to Target This Week and 1 We Find Risky

January 22, 2026

Megacap stocks are behemoths that set the tone for their industries, and their massive scale typically leads to wide moats. However, the downside is that most have already exploited their existing...

Via StockStory

The Trillion-Dollar Heavyweight: Eli Lilly Surge Signals Unrivaled Dominance in the GLP-1 Era

January 22, 2026

Eli Lilly (NYSE: LLY) has once again demonstrated its resilience and market-leading strength, logging a significant 5.2% gain over the last five trading days as of January 22, 2026. This recent rally...

Via MarketMinute

Topics Economy

The Great Broadening: Why Early 2026 is Redefining the Market’s Winning Ticket

January 22, 2026

As the first month of 2026 draws to a close, the narrative that dominated Wall Street for the better part of three years—the undisputed reign of mega-cap technology—is rapidly fracturing. In its place,...

Via MarketMinute

Topics Economy

< Previous 1 2

...

25 26 27 28 29 30 31 32 33

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.